UK dermal filler market: £500m and growing Next-generation PEG-HA technology Lip fillers: the UK's #1 injectable treatment
Clinic growth opportunity

The UK's most in-demand injectable — and the margin to match

Dermal fillers are now the single biggest revenue driver in UK aesthetic clinics, accounting for a significant share of the £500 million market. Neauvia PEG-HA fillers give your clinic access to next-generation technology that delivers longer-lasting, natural results with fewer complications — exactly what today's more informed patients are looking for. If you're not yet offering fillers, or want to upgrade what you're currently using, this is where to start.

Proven patient demandOver 52% of UK filler patients are under 35, and the market is adding a new demographic every year — from millennial preventative patients to a rapidly growing male audience.
Strong, repeat revenueFillers require maintenance every 6 to 18 months, depending on the area, making every new patient a reliable returning one, not a one-off booking.
Superior technologyNeauvia's PEG crosslinking offers improved stability, reduced post-treatment swelling, and a more natural result compared to standard HA fillers — giving your clinic a credible point of difference.

No obligation — response within 48 hours

Next-generation PEG-HA technology Full treatment range Built-in patient confidence Regulatory tailwind

Patients are already searching. Are they finding your clinic?

The UK dermal filler market is valued at £500 million and growing. The question isn't whether there's demand — it's whether your clinic is positioned to capture it.

£500m UK dermal filler market value (2024) A market growing at over 5.5% annually, with aesthetic clinics accounting for approximately 60% of all patient demand.
52% Of UK filler patients are under 35 The under-35 cohort is driving a "prejuvenation" trend — preventative treatments that create earlier patient relationships and longer lifetime value.
5.2m UK men considering dermal filler treatment A largely untapped audience: approximately 1 in 5 of these men say they are likely to book — representing a significant new revenue channel for clinics that actively market to them.
65% Of total UK aesthetics revenue comes from injectables Dermal fillers and anti-wrinkle treatments together dominate the sector — adding fillers to your menu is not a specialism, it's a commercial baseline.
Get My Free Clinic ROI Assessment

No obligation — one of our team will be in touch within 48 hours

The commercial case for dermal fillers

Strong margins, a broad patient base, and a natural repeat cycle make fillers one of the most commercially predictable treatments you can add to your menu.

Patient demand

A market that keeps growing — across every age group

The UK dermal filler market is forecast to reach £825 million by 2034. Millennials are currently the highest spenders, but Gen Z uptake is accelerating, and the male market is expanding fast. With 92% of aesthetic procedures now non-surgical, fillers sit at the very centre of patient demand.

Image coming soon
Repeat revenue

Every patient is a returning patient

Treatment longevity varies by area — lip fillers typically need refreshing every 6 to 12 months, while cheek and jawline treatments can last 12 to 18 months with advanced formulations. This creates a predictable maintenance cycle that supports patient retention without heavy re-marketing.

Image coming soon
Margin and pricing

£200 to £800 per session, with meaningful margin at every level

Typical cheek or jawline filler price per session

Image coming soon
12–18 months

Typical longevity of advanced HA cheek filler

Why Clinics Choose Neauvia Dermal Fillers

Neauvia dermal fillers work exceptionally well in my clinic due to their safety profile, excellent lift, and strong scientific foundation. Their proven heat stability allows me to confidently combine fillers with laser treatments, delivering efficient, high-impact results for my patients. My Neauvia “Glow Up” treatments consistently perform well and are a firm favourite with returning patients.

Dr Kathryn Taylor-Barnes
Dr Kathryn Taylor-Barnes

Neauvia fillers have become an integral part of our aesthetic practice. The science behind the products, its excellent tissue integration and predictable results, allows us to deliver safe, natural-looking outcomes for all our patients. Patient feedback has always been high, and we value Neauvia’s focus on innovation, quality, and biocompatibility.

Dr. Rome Candy
Dr. Rome Candy

What happens after you fill in the form

There's no sales pressure and no commitment — just a useful conversation to see whether this makes sense for your clinic.

1

We review your enquiry

Within 48 hours of submitting the form, one of our aesthetic specialists will review your details and get in touch by phone or email at a time that suits you. We'll have a brief, straightforward conversation about your clinic, your current treatment menu, and what you're looking to add or improve. No pitch, no hard sell — just a fact-finding call.

2

We put together a relevant proposal

Based on what you tell us, we'll outline which Neauvia products are most relevant for your patient base, walk you through pricing and margin, and answer any clinical or commercial questions you have. If you'd like to see product samples or supporting clinical data, we can arrange that too.

3

You decide, with no pressure

There's no obligation to proceed after an initial conversation. If you want time to think, compare options, or discuss with a colleague, that's entirely reasonable — and we'll leave the door open. If you do decide to move forward, we'll handle onboarding efficiently so you can start offering treatments with confidence.

Ready to see what fillers can add to your clinic?

Fill in the short form below and one of our team will be in touch within 48 hours with a no-obligation assessment tailored to your clinic. There's no pressure, no minimum commitment — just a straight conversation about whether Neauvia is the right fit for you.

We typically respond within 48 hours. No obligation to proceed.